期刊文献+

乳腺癌前哨淋巴结的定位活检和免疫组织化学检测 被引量:2

Biopsy and Immunohistochemical Characters of Sentinel Lymph Nodes in Patients with Breast Cancer
下载PDF
导出
摘要 目的 对应用HE染色和不同角蛋白免疫组化染色检测乳腺癌前哨淋巴结 (sentinellymphnode ,SLN)转移进行评价。方法  71例女性乳腺癌患者 ,腋窝均未扪及肿大腋淋巴结 ,分别采用染料、核素及联合应用染料与核素的方法进行淋巴示踪 ,其中 6 0例找到SLN ,切除SLN后行腋淋巴结切除术。对SLN和其它腋淋巴结的病理组织学特点进行分析比较 ,并对SLN分别以抗CKAE1/AE3 、抗CK7、抗CK2 0 用Envision法进行免疫组化染色。结果 在腋淋巴结阳性病人中SLN的转移率为 72 % ( 2 6 / 36 ) ,非SLN的转移率为 16 % ( 39/ 2 4 8) (P <0 .0 0 1)。对SLN进行角蛋白免疫组化染色 ,可使 5 .0 %的病人的病理分期提高。应用抗CK7、抗CK2 0 、抗CKAE1/AE3 染色的灵敏度分别为 10 0 %、3.9%、10 0 % ,特异度分别为 10 0 %、10 0 %、10 0 % ,阳性预测值分别为10 0 %、10 0 %、10 0 % ,阴性预测值分别为 10 0 %、74 .5 %、10 0 %。结论 抗CK7和抗CKAE1/AE3 用于检测乳腺癌前哨淋巴结肿瘤转移是敏感的指标 ,而抗CK2 0 对乳腺癌上皮细胞的敏感度差 ,不宜用于乳腺癌微转移的检测。对SLN应用免疫组化染色 ,可提高病理分期的准确性。 Purpose: To evaluate H. E. stain and immunohistochemical stain with different cytokeratine (CK) to examine the sentinel lymph node(SLN) metastasis in breast cancer. Methods: 71 female breast cancer patients with no palmed axillary lymph node underwent SLN localization using blue dye, technetium-labeled sulfur colloid or combination of them. SLN was found in 60 cases. Axillary dissection was done after SLN had been removed. The pathologic characters of SLNs and other axillary nodes were analyzed. SLNs were stained with immunohistochemical method by anti-CKAE1/AE3, anti-CK 7, anti-CK20. Results: The metastasis rate of SLN is 72% (26/36) and that of non-SLN is 16 % (39/248) in patients with positive axillary node(s) (P 7, anti-CK20, anti-CKAE1/AE3 is 100% , 3.9%, 100% . Specificity is 100%, 100%, 100%. Positive predictive value is 100%, 100%, 100%. Negative predictive value is 100%, 74. 5%, 100%. Conclusions: anti-CK AE1/AE3 and anti-CK7 can examine the metastasis of SLN sensitively. The sensitivity of anti-CK20 is poor. Immunohistochemical stain of SLN can increase the accuracy of pathologic stage of breast cancer.
出处 《复旦学报(医学版)》 EI CAS CSCD 北大核心 2004年第4期395-398,共4页 Fudan University Journal of Medical Sciences
关键词 乳腺癌 前哨淋巴结 定位活检 免疫组织化学 检测 Biopsy Colloids Histology Immunology Patient monitoring Tissue
  • 相关文献

参考文献6

  • 1Giuliano AE,Kirgan DM,Guenther JM,et al.Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann Surg,1994,220:391
  • 2Imoto S,Murakami K,Ikeda H,et al.Mammary lymphoscintigraphy with various radiopharmaceuticals in breast cancer.Ann Nucl Med,1999,13(5):325
  • 3Galimberti V,Zurrida S,Zucali P,et al.Can sentinel biopsy avoid axillary dissection in clinically node-negative breast cancer patients?Breast J,1998,7:8
  • 4Turner RR,Ollila DW,Krasne DL,et al.Histopathologic validation of the sentinel node hypothesis for breast carcinoma.Ann Surg,1997,226:271
  • 5Schreiber RH,Pendas S,Ku NN,et al.Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node.Ann Surg Oncol,1999,6(1):95
  • 6Orr RK,Hoehn JL,Col NF.The learning curve for sentinel node biopsy in breast cancer:practical considerations.Arch Surg,1999,134(7):764

同被引文献16

  • 1皋岚湘,丁华野.免疫组织化学在乳腺疾病鉴别诊断中的应用[J].诊断病理学杂志,2006,13(1):8-12. 被引量:11
  • 2Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clini-tally negative lymph nodes[J]. Lancet, 1997, 349:1864-1867.
  • 3Giuliano A E, Kirgan D M, Guenther J M, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer[J]. Ann Surg, 1994, 220:391.
  • 4Imoto S, Murakami K, Ikeda H, et al. Mammary lymohoscinti - graph with various radiopharmaceuticals in breast cancer[J]. Ann Nucl Med,1999, 13(5):325.
  • 5Galimberti V, Zurrida S, Zucali P, et al. Can sentinel biopsy avoid axillary dissection in clinically node-negative breast cancer patient[J]. Breast J, 1998, 7:8.
  • 6Giulano A E, Kirgan D M, Guenther J M, et al. Lymphatic mapping and sentinel lymphadenctomy for breast cancer [J]. Ann Surg, 1994, 220(3):391-398.
  • 7Turner R R, Ollila D W, Krasne D L,et al. Histopathologic validation of the sentinel node hypothesis for breast carcinoma [J]. Ann Surg, 1997, 226:271.
  • 8Schreiber R H, Pendas S, Ku N N, et al. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node[J]. Ann Surg Oncol, 1999, 6(1):95.
  • 9Stathoulos E N, Sanidas E, Kafousi M, el al. Eteetion of CK19 mRNA -Pocesitive cells in the peripheral blood of breast cancer patients with histologically and immunohistc-hemieally negarive axillarylymphnodes[J]. Ann Ontol, 2005, 16:240-246.
  • 10Rosen P P, lesser M L, Kinne D M. et at. Discontinuous or skip metastasis in breast carcinoma: analysis of 1228 axillary dissec tions[J]. Ann Surg, 1983, 197(3):276-283.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部